Foley Hoag offers our venture capital and emerging company clients highly experienced, issue-focused counsel, which is integrated with our full-service practice. Our lawyers, working with other members of our firm, can provide you with assistance for all of your matters, even if they reach beyond traditional venture capital and emerging company issues. learn more

News more

  • Foley Hoag Selected as one of 2008 Top 100 Law Firms for Diversity  [Read More]
  • Bruce Quinn, MD, PhD Joins the Foley Hoag Government Strategies Practice as Health Policy Specialist  [Read More]
  • Foley Hoag Names Three New Partners  [Read More]
  • Two Foley Hoag Lawyers Recognized by Washingtonian Magazine as Area's Best Lawyers  [Read More]
  • Chambers Global 2008 Releases Rankings  [Read More]

Publications more

  • Auditor Liability in Securities Litigation from a Defensive Perspective [Read More]
  • Prescription Drug Pedigree: Proliferation of State Laws Calls for Federal Action [Read More]
  • The Benefits of Patent Marking – And of Getting It Right [Read More]
  • Health Canada Releases Draft Biosimilar Approval Guidance [Read More]
  • Recent Regulatory and Industry Moves Make Clear the Importance of Addressing Potential Indoor Air Contamination Issues [Read More]

Events more

May 15, 2008 Skidmore Business Network presents Richard Laxer, '83 ~ President and CEO, GE Capital Solutions [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 16, 2008 Technologies to Enhance Training [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 20, 2008 Deciphering the Funding Value-Chain: How Seed Capital Scroungers Become Bankers' Best Friends [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 21, 2008 Shining the Light on You: Catching the Interest and Capturing Investment Dollars in Today's Turbulent Markets for Small and Microcap Companies [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA
May 21, 2008 Boston Technology Leadership Council [Read More] Emerging Enterprise Center at Foley Hoag
Waltham, MA

Client Successes more

  • Biomedical Advanced Research and Development Authority (BARDA)
    In a move that created enormous opportunities for early-stage life sciences companies, last year the U.S. Congress revitalized the federal government’s program supporting the development of medical countermeasures critical to protecting the nation against bioterrorism and pandemic threats. The resulting legislation created an agency within the Department of Health and Human Services (HHS), the Biomedical Advanced Research and Development Authority (BARDA). BARDA will inject more than $1 billion into research, development, and procurement of vaccines, antivirals and diagnostics. BARDA enhances coordination between government and emerging companies through support of advanced research and development, the vital phase that occurs in between basic research and commercialization. On behalf of the venture capital firm, Kleiner Perkins Caulfield & Byers, Foley Hoag worked with the HHS, Congressional members, and staff to craft legislation strengthening the nation’s response to pandemic outbreaks and bioterrorism. The key financing aspect of the legislation provides much-needed funding to allow early stage companies to traverse the “valley of death” before product commercialization. The legislation authorizes the Secretary of HHS to expedite contracts and grants, and the Director of BARDA to identify areas of unmet need, spurring further innovation and investment. BARDA institutionalizes the important partnership between the federal government and the life sciences industry, critical to safety, innovation and economic vitality. [Read More]
  • Cellulosic Biomass Conversion
    Our lawyers provided general business advice and assistance with venture capital financing and technology licensing for a new corporation developing and commercializing technology for converting cellulosic biomass and other biomass wastes into ethanol. [Read More]

Blog more